Emotional distress and clinical response to neoadjuvant chemoimmunotherapy in resectable non-small-cell lung cancer: a protocol for the prospective observational NeoFUSE-Lung cohort study
Yuanpu Wei, Hancheng Yin, Deliang Hou, Hao Chen, Guobing Xu, Bin Zheng, Chun Chen, Zhang Yang · 2026
Read Emotional distress and clinical response to neoadjuvant chemoimmunotherapy in resectable non-small-cell lung cancer: a protocol for the prospective observational NeoFUSE-Lung cohort study by Yuanpu Wei, Hancheng Yin, Deliang Hou, Hao Chen, Guobing Xu, Bin Zheng, Chun Chen, Zhang Yang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13557886.txt.
Description
Yuanpu Wei and seven colleagues set out a 2026 protocol for a cohort study asking whether emotional distress changes how lung cancer patients respond to treatment given before surgery. Chemotherapy plus immunotherapy has improved results in operable non-small cell lung cancer, yet responses vary widely. Distress may dampen anti-tumour immunity through hormone and immune pathways, and this study will test that idea prospectively at one Fujian hospital.
Patients with stage II to IIIB disease receiving the drug combination as routine care will complete a standard anxiety and depression scale before treatment and after two cycles. Stool samples and blood markers will explore stress biology and gut microbes alongside the mood scores. Survival, tumour shrinkage, surgical pathology results, and quality of life form the outcome set. The design lets distress trajectories, not just a single snapshot, be tied to results.
Catalog record
| CREATOR | Yuanpu Wei, Hancheng Yin, Deliang Hou, Hao Chen, Guobing Xu, Bin Zheng, Chun Chen, Zhang Yang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 42651 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |